Form 4 · Filed May 28, 2026, 08:33 PM UTC
TMCI/TREACE MEDICAL CONCEPTS, INC.
Treace John T. — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 28, 2026 | P | buy | 61,202 | $3 | $184,824 | 7,273,833 |
| May 27, 2026 | P | buy | 49,810 | $3 | $143,189 | 7,212,631 |
| May 26, 2026 | P | buy | 4,508 | $3 | $12,576 | 7,162,821 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-245341